SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-069879
Filing Date
2021-05-20
Accepted
2021-05-20 16:06:04
Documents
1
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2117061-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2117061-1_4seq1.xml 4 4270
  Complete submission text file 0001104659-21-069879.txt   5696
Mailing Address C/O MYOS CORPORATION 45 HORSEHILL ROAD, SUITE 106 CEDAR KNOLLS NJ 07927
Business Address
Einhorn Andrew J. (Reporting) CIK: 0001560685 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 21944514

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations